» Articles » PMID: 35481576

Serological Response After SARS-CoV2 Vaccination in Healthcare Workers: a Multicenter Study

Abstract

Introduction: Characterizing immunological response following COVID-19 vaccination is an important public health issue. The objectives of the present analysis were to investigate the proportion, level and the determinants of humoral response from 21 days to three months after the first dose in vaccinated healthcare workers (HCWs).

Methods: We abstracted data on level of anti-SARS-CoV-2 Spike antibodies (IgG) and sociodemographic characteristics of 17,257 HCWs from public hospitals and public health authorities from three centers in Northern Italy who underwent COVID-19 vaccination (average 70.6 days after first dose). We fitted center-specific multivariate regression models and combined them using random-effects meta-analyses.

Results: A humoral response was elicited in 99.3% of vaccinated HCW. Female sex, young age, and previous COVID-19 infection were predictors of post-vaccination antibody level, and a positive association was also detected with pre-vaccination serology level and with time between pre- and post-vaccination testing, while a decline of antibody level was suggested with time since vaccination.

Conclusions: These results stress the importance of analyzing retrospective data collected via occupational health surveillance of HCWs during the COVID-19 epidemic and following vaccination. They need to be confirmed in larger series based on prospectively collected data.

Citing Articles

The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review.

Gurksniene V, Alcauskas T, Majauskaite F, Jancoriene L Vaccines (Basel). 2025; 12(12.

PMID: 39772080 PMC: 11680401. DOI: 10.3390/vaccines12121419.


Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge-ORCHESTRA project.

Spiteri G, DAgostini M, Abedini M, Ditano G, Collatuzzo G, Boffetta P Infection. 2024; 52(4):1347-1356.

PMID: 38326526 PMC: 11289150. DOI: 10.1007/s15010-024-02189-x.


COVID-19 Marked a Change in the Scope of Occupational Medicine from Occupational to Work-Related Diseases and Total Worker Health®.

Corradi M, Ranzieri S Med Lav. 2023; 114(6):e2023053.

PMID: 38060207 PMC: 10731568. DOI: 10.23749/mdl.v114i6.15429.


Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project.

Leomanni L, Collatuzzo G, Sansone E, Sala E, De Palma G, Porru S Vaccines (Basel). 2023; 11(10).

PMID: 37896931 PMC: 10610704. DOI: 10.3390/vaccines11101527.


Effects of Biological Sex and Pregnancy on SARS-CoV-2 Pathogenesis and Vaccine Outcomes.

Shapiro J, Roberts C, Arcovio K, Reade L, Klein S, Dhakal S Curr Top Microbiol Immunol. 2023; 441:75-110.

PMID: 37695426 DOI: 10.1007/978-3-031-35139-6_4.


References
1.
Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B . How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015; 14(3):309-21. PMC: 4406660. DOI: 10.1111/acel.12326. View

2.
Baker M, Peckham T, Seixas N . Estimating the burden of United States workers exposed to infection or disease: A key factor in containing risk of COVID-19 infection. PLoS One. 2020; 15(4):e0232452. PMC: 7188235. DOI: 10.1371/journal.pone.0232452. View

3.
Chen X, Chen Z, Azman A, Sun R, Lu W, Zheng N . Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis. Clin Infect Dis. 2021; 74(4):734-742. PMC: 9016754. DOI: 10.1093/cid/ciab646. View

4.
Klein S, Jedlicka A, Pekosz A . The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010; 10(5):338-49. PMC: 6467501. DOI: 10.1016/S1473-3099(10)70049-9. View

5.
Le T, Andreadakis Z, Kumar A, Roman R, Tollefsen S, Saville M . The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306. DOI: 10.1038/d41573-020-00073-5. View